Some AI researchers hailed DeepSeek’s R1 as a breakthrough on the same level as DeepMind’s AlphaZero, a 2017 model that became superhuman at the board games Chess and Go by purely playing against itself and improving, rather than observing any human games.

This new approach, based on natural selection, dramatically improves the reliability of large language models for practical tasks like trip planning. Here's how it works.

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The Chinese startup DeepSeek released an AI reasoning model that appears to rival the abilities of a frontier model from OpenAI, the maker of ChatGPT.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully have

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, documents obtained by The Post show.

A demo car ad created with Veo 2 from Google DeepMind is so realistic that it's hard to spot the amazing locations, intriguing people and fast cars are all AI.

Google DeepMind’s Lila Ibrahim writes how organizations can improve innovation and get people more likely to embrace AI

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

A string of startups are racing to build models that can produce better and better software. They claim it’s the shortest path to AGI.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. "We'll hopefully have some AI-designed drugs in clinical trials by the end of the year,